AnGes USA, Inc.: Clinical Trials

6 trials sponsored by AnGes USA, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Unknown 1
Phase 31Terminated 1

Follow AnGes USA, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers
AMG0001, Placebo - Peripheral Artery Disease, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease
Phase 2UnknownAnGes USA, Inc.602020-01-302021-12-22
A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia
Subjects from Study AG-CLI-0206 who received AMG0001 - Critical Limb Ischemia
CompletedAnGes USA, Inc.92017-02-202020-03-12
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
HGF Plasmid (AMG0001), Matching Placebo - Critical Limb Ischemia
Phase 3TerminatedAnGes USA, Inc.462014-11-122019-08-13
A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
HGF Plasmid - Critical Limb Ischemia, Vascular Diseases
Phase 2CompletedAnGes USA, Inc.102013-11-012021-01-22
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
HGF plasmid, Placebo - Arterial Occlusive Disease, Peripheral Vascular Disease
Phase 2CompletedAnGes USA, Inc.272005-08-012021-10-28
Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia
HGF plasmid - Arterial Occlusive Disease, Peripheral Vascular Disease
Phase 2CompletedAnGes USA, Inc.1042003-04-012008-01-11

Conditions studied

Chronic Limb-Threatening Ischemia (6)  ·  Arterial Occlusive Diseases (2)  ·  Ischemia (2)  ·  Peripheral Arterial Disease (2)  ·  Peripheral Vascular Diseases (2)  ·  Ulcer (1)  ·  Vascular Diseases (1)

Countries

United States (6)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Richard Powell, MD (3)  ·  David G Armstrong, MD, DPM, PhD (1)  ·  Michael S Conte, MD (1)  ·  Richard J. Powell, MD (1)

Results publications

PMID 18559703, PMID 21146749, PMID 41186002

NIH funding

2014 (1), 2016 (1)